Showing results (211-220 of 292) with videos related to

Sort By:
Pageof 30
Clinical Pharmacology : Advances and Applications|August 12, 2026
Recent Advances and Emerging Pharmacotherapeutic Approaches for Central Hypersomnolence DisordersKatyayini Aribindi, Tanwe C Shende, Timothy E Albertson
Clinical Pharmacology : Advances and Applications|October 16, 2020
Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial StudyAli Reza Sobhani, Hossein Farshidi, Fariba Azarkish, et al.
Clinical Pharmacology : Advances and Applications|April 12, 2022
Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019Rayan Hamza Mohammed Ahmedalgabri, Tarig Omer, Fatima Zarroug, et al.
Clinical Pharmacology : Advances and Applications|December 20, 2013
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjectsYimin Cui, Yan Song, Jessie Wang, et al.
Clinical Pharmacology : Advances and Applications|December 20, 2013
Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel responseRolf P Kreutz, Janelle Owens, Yan Jin, et al.
Clinical Pharmacology : Advances and Applications|August 2, 2017
NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatmentWilliam G North, Fuli Liu, Liz Z Lin, et al.
Clinical Pharmacology : Advances and Applications|July 20, 2017
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsySoujanya Sunkaraneni, Julie A Passarell, Elizabeth A Ludwig, et al.
Clinical Pharmacology : Advances and Applications|July 20, 2017
Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective studySanjeev Guragain, Namrata Upadhayay, Bishwa Mohan Bhattarai
Clinical Pharmacology : Advances and Applications|July 25, 2022
Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory HypercholesterolemiaConstantine E Kosmas, Maria D Bousvarou, Andreas Sourlas, et al.
Clinical Pharmacology : Advances and Applications|October 2, 2019
Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetesIoanna Papakitsou, George Vougiouklakis, Moses S Elisaf, et al.
Pageof 30